PT  - JOURNAL ARTICLE
AU  - Bittner, Dennis
ED  - Holsboer, Florian
TI  - New Approaches Required in Drug Development Process for Antidepressants
DP  - 2015 Sep 11
TA  - MD Conference Express
PG  - 17--18
VI  - 15
IP  - 11
4099  - http://mdc.sagepub.com/content/15/11/17.short
4100  - http://mdc.sagepub.com/content/15/11/17.full
AB  - Florian Holsboer, director of the Max-Planck Institute for Psychiatry for 25 years, called for a reengineering of the drug development process for antidepressants, meaning a shift from a focus on blockbuster drugs capable of treating all depression to use of biomarkers to target subsets of patients based on disease etiology.